DrugDashboards

Lacosamide

Lacosamide · LACOSAMIDE 150 mg/1 · Tablet · Oral · Tris Pharma Inc

NDC 27808-0245-01 · 60 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 18% over the past year, to $0.2856 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2856per EAinvoice-surveyed acquisition cost · Feb 19, 2025
  • Part D plans paid (avg)$1.50per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.2625per TABweighted avg manufacturer price $0.1418 · Jan 1, 202592% of what pharmacies pay — a deeper discount than 95% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4$0.6Jun 2022Feb 2025$0.2856
34 price points · per EA · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$8.57
#90 count
$25.70

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2024)

$479
14 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

5● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 5 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for lacosamide (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · 1 Class I/II recall(s) in 12 months

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA208308
TE code
AB
Approval date
Mar 17, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lacosamide (Tablet)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals of New York LLCLACOSAMIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCLACOSAMIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCLACOSAMIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCLACOSAMIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Florida Pharmaceutical Products, LLCLACOSAMIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Florida Pharmaceutical Products, LLCLACOSAMIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Florida Pharmaceutical Products, LLCLACOSAMIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Florida Pharmaceutical Products, LLCLACOSAMIDE 200 mg/1Jul 15, 2026Sep 2, 2026
Indoco Remedies LimitedLACOSAMIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Indoco Remedies LimitedLACOSAMIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Indoco Remedies LimitedLACOSAMIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Indoco Remedies LimitedLACOSAMIDE 200 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCLACOSAMIDE 200 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCLACOSAMIDE 150 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCLACOSAMIDE 100 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCLACOSAMIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Tris Pharma IncLACOSAMIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Tris Pharma IncLACOSAMIDE 100 mg/1Jul 15, 2026Sep 2, 2026
Tris Pharma IncLACOSAMIDE 150 mg/1Jul 15, 2026Sep 2, 2026
Tris Pharma IncLACOSAMIDE 200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lacosamide — NDC 27808-0245-01," retrieved September 3, 2026, https://drugdashboards.com/drug/27808024501.

Free to cite with attribution — see how the data is put together.